Patents Examined by Sin J. Lee
  • Patent number: 11655437
    Abstract: A peroxide delivery system is produced. The peroxide delivery system includes a dry powder that releases the peroxide quickly and completely when needed. The peroxide delivery system may be produced by combining a liquid peroxide or peroxide solution with an inorganic solid support that is inert to the peroxide and is capable of adsorbing large amounts of the liquid peroxide or peroxide solution while remaining dry to the touch. Methods of combining the inorganic solid support with the liquid peroxide or peroxide solution are disclosed. The peroxide delivery system can be formulated in preparations of powders, liquids, foams, sprays, gels, ointments, creams, sticks, or pastes that can be utilized in a variety of applications such as cleaning, stain removal and antiseptic products, for example.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: May 23, 2023
    Assignee: Arkema Inc.
    Inventors: Christian Guy Becker, Pan Pan
  • Patent number: 11590161
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: February 28, 2023
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • Patent number: 11590068
    Abstract: The invention relates to a personal care product for alleviating skin dryness, includes facial skin dryness, breast skin dryness and vulval dryness and for restoring vaginal flora, acidic pH in the vagina, and vaginal health. Embodiments of the personal care product include a formulation including at least about 83 wt. % plant-based glycerides; from about 0.05 wt. % to about 0.15 wt. % sodium hyaluronate; and from about 0.01 wt. % to about 1.5 wt. % sea buckthorn powder. Another embodiment includes a personal care product including at least 55 wt. % plant-based glycerides and from about 20 wt. % to about 42 wt. % sucrose. The personal care product may also include shea olein. The person care product is substantially free of added water, alcohol, synthetic chemical, anti-microbial agent, and synthetic hormone.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: February 28, 2023
    Assignee: DAMIVA INC.
    Inventors: Gardiner F. H. Smith, Chia Chia Sun
  • Patent number: 11583485
    Abstract: Antiperspirant and/or deodorant compositions and methods for the same are provided. The compositions may include an antiperspirant active or a deodorant active, water, and a preservative system. The antiperspirant active may include aluminum, and the preservative system may include a biodegradable amino carboxylate. The methods may include substituting or replacing a conventional chelant, such as EDTA, with a biodegradable chelant, such as HIDS. The methods may also include applying one of the compositions to an axillary area of a person.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: February 21, 2023
    Assignee: Colgate-Palmolive Company
    Inventors: Daniel Schankel, Viktor Dubovoy, Richard Adams, Sandra Wadeer, Christine Boyke, Long Pan, Ravi Subramanyam
  • Patent number: 11576851
    Abstract: A composition comprising at least one dispersed fatty phase, and at least one continuous aqueous phase, and comprising: a) at least one hydrophobic gelling agent selected from ester of dextrin and fatty acid; b) at least one amphiphilic crosslinked copolymer; c) at least one anionic terpolymer, linear or branched, of at least one monomer (1) carrying an acid function in free form, partially or totally salified by a nonionic monomer (2) selected from N,N-dimethylacrylamide and 2-hydroxyethyl acrylate, and at least one monomer (3) polyoxethylenated alkyl acrylate of formula (III) wherein in formula (III): R1 represents a hydrogen atom, R represents a linear or branched C8-C16 alkyl radical, n is an integer ranging from 1 to 10; and d) at least one hydrophobic particles chosen from hydrophobic silicas, hydrophobic cellulose, starch, talc, silicone resin powders, hollow hemispherical silicone particles, polyamide powders, hydrophobic pigments, or a mixture thereof.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: February 14, 2023
    Assignee: L'OREAL
    Inventors: Huiqin Chen, Xiaomin Weng
  • Patent number: 11576929
    Abstract: This invention provides a more efficient means for treating inflammatory gastrointestinal diseases using CO. More specifically, the invention provides a composition for preventing and/or treating inflammatory gastrointestinal diseases, the composition comprising carbon monoxide and a solvent, the CO concentration being 800 ?M or more.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: February 14, 2023
    Inventors: Tomohisa Takagi, Yuji Naito, Katsura Miura, Shigeki Sakaue
  • Patent number: 11559602
    Abstract: The purpose of the present invention is to provide an injectable sol into a body, suited for delivery through a catheter, and usable for tissue perforation closure, ulcer protection, or vascular embolization. Provided are a sol for tissue perforation closure, a sol for ulcer protection, and a sol for vascular embolization, each containing from 0.6 mass % to 3 mass % of a collagen, water, from 200 mM to 330 mM sodium chloride, and a buffer and having a pH from 6.0 to 9.0.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: January 24, 2023
    Assignees: Tokyo Metropolitan Industrial Technology Research Institute, National University Corporation Gunma University
    Inventors: Toshio Uraoka, Naohisa Yahagi, Shunji Yunoki, Yoshimi Ohyabu, Takefumi Narita
  • Patent number: 11559490
    Abstract: A pharmaceutical formulation has (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: January 24, 2023
    Assignee: Merck Patent GmbH
    Inventors: Simon Geissler, Martina Jeschke, Patrizia Boniforte, Markus Weigandt
  • Patent number: 11547710
    Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and a statin and to methods of using the same to treat or prevent cardiovascular-related diseases.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: January 10, 2023
    Assignee: Amarin Pharmaceuticals Ireland Limited
    Inventor: George Grandolfi
  • Patent number: 11541007
    Abstract: A pharmaceutical composition containing a mixed polymeric micelle and a drug enclosed in the micelle, in which the mixed polymeric micelle, 1 to 1000 nm in size, includes an amphiphilic block copolymer and a lipopolymer. Also disclosed are preparation of the pharmaceutical composition and use thereof for treating cancer.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: January 3, 2023
    Assignee: MegaPro Biomedical Co., Ltd.
    Inventors: Ming-Cheng Wei, Yuan-Hung Hsu, Wen-Yuan Hsieh, Chia-Wen Huang, Chih-Lung Chen, Jhih-Yun Jian, Shian-Jy Wang
  • Patent number: 11540998
    Abstract: A low-viscosity water-in-oil cosmetic emulsion preparation gives a smooth use feeling, lightly spreads when applied, and has excellent dispersed-powder stability. The cosmetic emulsion preparation has (A) a polar oil which is liquid at 25° C. and has an IOB value exceeding 0.1, (B) a hydrocarbon oil, (C) a polyoxyalkylene; and alkyl-modified organopolysiloxane represented by general formula (I), and (D) a powder surface-treated with both an N-acylamino acid and methylpolysiloxane. (In formula (I), R represents a hydrogen atom or a C1-5 alkyl group, x is an integer of 5-50, y is an integer of 1-30, z is an integer of 20-200, a is an integer of 2-20, b is an integer of 1-5, c is an integer of 2-20, and d is an integer of 0-20).
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: January 3, 2023
    Inventors: Yukiko Sato, Tomoko Ikeda
  • Patent number: 11534401
    Abstract: A room temperature injectable thermo-responsive hydrogel comprises a P407 poloxamer base hydrogel, chitosan, 2-Hydroxypropyl ?-cyclodextrin and genipin. The chitosan and genipin form an interpenetrating scaffold within the hydrogel in which the chitosan is crosslinked with genipin. Chemotherapeutic drugs can be added to the hydrogel singly or in combination in effective amounts without any loss of thermo-responsiveness in the hydrogel. Therapeutic use of the thermo-responsive hydrogel in the intratumoural treatment of solid cancer is also described.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: December 27, 2022
    Inventors: Helena Kelly, Garry Duffy, Seona Rossi, Conn Hastings
  • Patent number: 11534386
    Abstract: Emulsion comprising an anionic acrylic copolymer and a lipophilic polymer A subject of the present invention is a composition in the form of an emulsion, preferably in the form of an oil-in-water emulsion, comprising at least one hydrophilic gelling polymer chosen from anionic acrylic copolymers and at least one lipophilic polymer comprising at least hydroxyethyl acrylate units and acrylate units bearing a lipophilic group, wherein the weight ratio of the sum of all the hydroxyethyl acrylate units to the sum of all the acrylate units bearing a lipophilic group ranges from 1:30 to 1:1 and wherein the lipophilic polymer has a number-average molecular weight Mn ranging from 2000 to 9000 g/mol. The composition in accordance with the invention makes it possible to obtain emulsions which are homogeneous (the emulsion is macroscopically smooth and has no grains, after storage in a pot for 24 hours at ambient temperature (25° C.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: December 27, 2022
    Assignee: L'OREAL
    Inventors: Laure Fageon, Carole Guiramand, Karl Boutelet
  • Patent number: 11524029
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: December 13, 2022
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • Patent number: 11517548
    Abstract: A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: December 6, 2022
    Assignee: Impel Pharmaceuticals Inc.
    Inventors: John D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera
  • Patent number: 11504309
    Abstract: The present disclosure concerns a deodorant emulsion for an aerosol spray which is free from aluminum salts and ethanol, comprising: at least one emulsifier, at least one salt, water, at least one silicone oil and at least one further oil, and a deodorant aerosol spray product comprising a pressure or pump spray container with spray head, the filling of which comprises the deodorant emulsion and optionally a propellant and/or further solvent, and a use of the deodorant aerosol spray product for deodorizing human skin.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: November 22, 2022
    Assignee: HENKEL AG & CO. KGAA
    Inventors: Iris Marina Stadler, Daniel Solich, Inga Kerstin Vockenroth
  • Patent number: 11478410
    Abstract: The invention provides a liquid cosmetic that contains capsule in an aqueous medium, wherein the capsule comprises agar shell encapsulating an oil component, and the aqueous medium comprises a low molecular polyol and one selected from the group consisting of a (meth)acrylic polymer and a polysaccharide.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: October 25, 2022
    Assignee: LVMH RECHERCHE
    Inventors: Masahiro Kikuchi, Mai Ozawa, Takayoshi Sakoda
  • Patent number: 11464792
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: October 11, 2022
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Patent number: 11464723
    Abstract: Personal care composition having superior moisturizing, slipperiness and evacuation rate properties are disclosed.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: October 11, 2022
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Hortense Baillet, Marie Ceclie Geslin
  • Patent number: 11458162
    Abstract: The present invention relates to compositions and methods for controlling a gag reflex in a patient.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: October 4, 2022
    Inventors: Robert Olson, Deshka Olson, Wayne Provost